tRNS for ADHD
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new treatment called transcranial random noise stimulation (tRNS) to determine if it can safely and effectively help children with ADHD improve their attention. tRNS is a non-invasive technique that delivers gentle electrical signals to the brain. Participants will receive either the actual tRNS treatment or a sham (inactive) version, both involving a 20-minute session over 10 days. Children with moderate to severe ADHD who have not recently taken ADHD medication might be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research in ADHD treatment.
Will I have to stop taking my current medications?
Yes, you must stop taking any medications that affect the central nervous system, including ADHD medications, at least 7 days before joining the trial.
What prior data suggests that tRNS is safe for pediatric patients with ADHD?
Research has shown that transcranial random noise stimulation (tRNS) is generally well-tolerated. One study found that tRNS improved thinking and decision-making skills in children with ADHD without causing significant side effects. This suggests the treatment is generally safe for young patients.
tRNS belongs to a group of treatments called transcranial electrical stimulation (tES), known for its safety. This makes tRNS a promising option for children and teenagers with ADHD, as research indicates it is both effective and safe.12345Why are researchers excited about this trial?
Researchers are excited about tRNS (transcranial random noise stimulation) for ADHD because it offers a non-invasive approach that could provide a new way to manage symptoms. Unlike traditional treatments like medication, which often target neurotransmitter balance, tRNS uses electrical stimulation applied to the scalp to potentially enhance brain function. This method might improve attention and focus without the side effects commonly associated with ADHD medications. Additionally, its non-invasive nature means it could be a safer option for children and adults who struggle with medication adherence or tolerance.
What evidence suggests that tRNS is effective for ADHD?
Research shows that transcranial random noise stimulation (tRNS), a treatment participants in this trial may receive, may help with ADHD. Studies have found that tRNS can improve attention-related skills, such as self-control and memory. Parents have observed improvements in their children's ADHD symptoms following tRNS treatment. Additionally, tRNS has helped individuals with ADHD better judge time. These findings suggest that tRNS might effectively address key symptoms of ADHD.12678
Who Is on the Research Team?
Paul Croarkin
Principal Investigator
Mayo Clinic
Eric Storch
Principal Investigator
Baylor College of Medicine
Are You a Good Fit for This Trial?
This trial is for children aged 7-12 with ADHD who haven't taken medication for it. They'll be part of a study where they receive tRNS, a noninvasive brain stimulation, while playing a game to help focus their attention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either tRNS or sham treatment for 10 days during a two-week period in a home-simulated environment. Each session is 20 minutes.
Follow-up 1
Participants are monitored for changes in ADHD symptom severity and adverse events.
Follow-up 2
Further monitoring of ADHD symptom severity and adverse events.
What Are the Treatments Tested in This Trial?
Interventions
- tRNS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Innosphere
Lead Sponsor